An integrated in silico analysis of drug-binding to human serum albumin

Journal of Chemical Information and Modeling

Volumn 46, Issue 6, 2006, Pages 2709-2724

  Estrada, Ernesto ^a   Uriarte, Eugenio ^b   Molina, Enrique ^a   Simón Manso, Yamil ^c   Milne, George W A ^d  

^a Edificio CACTUS   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^d NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROPHOBICITY; MATHEMATICAL MODELS; MOLECULAR DYNAMICS; PHARMACOKINETICS; PROTEINS;

DRUG BINDING; HUMAN SERUM ALBUMIN; IN SILICO ANALYSIS; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS (QSAR);

DRUG PRODUCTS;

SERUM ALBUMIN;

ALGORITHM; ARTICLE; BINDING SITE; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER PROGRAM; DRUG DESIGN; HUMAN; INFORMATION SCIENCE; METHODOLOGY; PHARMACEUTICS; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL MODEL;

ALGORITHMS; BINDING SITES; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; HUMANS; INFORMATICS; MODELS, CHEMICAL; MODELS, MOLECULAR; MODELS, STATISTICAL; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SERUM ALBUMIN; SOFTWARE; TECHNOLOGY, PHARMACEUTICAL;

EID: 33845733253     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci600274f     Document Type: Article

References (64)

1. Butina, D.; Segall, M. D.; Frankcombe, K. Predicting ADME Properties in Silica: Methods and Models. Drug Discovery Today 2002, 7, S83-S88.
2. van de Waterbeemd, H.; Gifford, E. ADMET in Silica Modeling: Towards Prediction Paradise? Nat. Rev. 2003, 2, 192-204.
3. Delisle, R. K.; Jowrie, J. F.; Hobbs, D. W.; Diller, J. Computational ADME/Tox Modeling: Aiding Understanding and Enhancing Decision Making in Drug Design. Curr. Comput.-Aided Drug Des. 2003, 1, 325-345.
4. Bidault, Y. A Flexible Approach for Optimizing in Silica ADME/Tox Characterization of Lead Candidates. Exp. Opin. Drug Metab. Tox. 2006, 2, 157-168.
5. Eriksson, L.; Jaworska, J.; Worth, A. P.; Cronin, M. T. D.; McDowell, R. M.; Gramatica, P. Methods for Reliability and Uncertainty Assessment and for Applicability Evaluations of Classification- and Regression-Based QSARs. Environ. Health Perspect. 2003, 111, 1361-1375.
6. Dimasi, J. A. Risk in New Drug Development Approval Success Rates for Investigational Drugs. Clin. Pharmacol. Ther. 2001, 69, 297-307.
7. Urien, S.; Tillement, J. P.; Barré, J. The Significance of Plasma -Protein Binding in Drug Research. In Pharmacokinetic Optimization in Drug Research; Testa, B., van de Waterbeemd, H., Folkers, G., Guy, R. H., Eds.; Wiley VCH: Zürich, Switzerland, 2001; pp 189-197.
8. Peters, T., Jr. All About Albumin, Biochemistry, Genetics, and Medical Applications; Academic Press: New York, 1996; pp 79-131.
9. Carter, D. C.; Ho, J. X. Structure of Serum Albumin. Adv. Protein Chem. 1994, 45, 152-203.
10. Xiao, M. H.; Carter, D. C. Atomic Structure and Chemistry of Human Serum Albumin. Nature (London) 1992, 358, 209-215.
11. Sudlow, G.; Birkett, D. J.; Wade, D. H. Characterization of Two Specific Drug Binding Sides on Human Serum Albumin. Mol. Pharmacol. 1975, 12, 1052-1061.
12. Petitpas, I.; Bhattacharya, A. A.; Twine, S.; East, M.; Curry, S. Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin. J. Biol. Chem. 2001, 276, 22804-22809.
13. Bhattacharya, A. A.; Curry, S.; Franks, N. P. Binding of General Anesthetics Propofol and Halothane to Human Serum Albumin: High-Resolution Crystal Structures. J. Biol. Chem. 2000, 275, 38731-38738.
14. Ghuman, J.J.; Zunszain, P. A.; Petitpas, I.; Bhattacharya, A. A.; Otagiri, M.; Curry, S. Structural Basis of the Drug-Binding Specificity of Human Serum Albumin. J. Mol. Biol. 2005, 353, 38-52.
15. Kragh-Hansen, U.; Chuang, V. T. G.; Otagiri, M. Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin. Biol. Pharm. Bull. 2002, 25, 695-704.
16. Colmenarejo, G. In Silica Prediction of Drug-Binding Strengths to Human Serum Albumin. Med. Res. Rev. 2003, 23, 275-301.
17. Kratochril, N. A.; Huber, W.; Müller, F.; Kansy, M.; Gerber, P. R. Predicting Plasma Protein Binding of Drugs: Revisited. Curr. Opin. Drug Discovery Dev. 2004, 7, 507-512.
18. Colmenarejo, G.; Alvarez-Pedraglio, A.; Lavandera, J. L. Cheminformatic Models to Predict Binding Affinities to Human Serum Albumin. J. Med. Chem. 2001, 44, 4370-4378.
19. Hall, L. M.; Hall, L. H.; Kier, L. B. Modeling Drug Binding Affinity with E-State Topological Structure Representation. J. Chem. Inf. Comput. Sci. 2003, 43, 2120-2128.
20. Xue, C. X.; Zhang, H. X.; Liu, X. J.; Yao, M. C.; Liu, Z. D.; Fan, B. T. QSAR Models for the Prediction of Binding Affinities to Human Serum Albumin Using the Heuristic Method and a Support Vector Machine. J. Chem. Inf. Comput. Sci. 2004, 44, 1693-1700.
21. Gunturi, S. B.; Narayanan, R.; Khandelwal, A. In Silica ADME Modelling 2: Computational Models to Predict Human Serum Albumin Binding Affinity Using Ant Colony Systems. Bioorg. Med. Chem. 2006, 14, 4118-4129.
22. Díaz, N.; Suárez, D.; Sordo, T. L.; Merz, K. M., Jr. Molecular Dynamics Study of the IIA Binding Site in Human Serum Albumin: Influence of the Protonation State of Lys195 and Lys199. J. Med. Chem. 2001, 44, 250-260.
23. Ermondi, G.; Lorenti, M.; Caron, G. Contribution of Ionization and Lipophilicity to Drug Binding to Albumin: A Preliminary Step toward Biodistribution Prediction. J. Med. Chem. 2004, 47, 3949-3961.
24. Estrada, E.; Uriarte, E. Recent Advance on the Role of Topological Indices in Drug Discovery Research. Curr. Med. Chem. 2001, 8, 1573-1588.
25. Estrada, E. Extracting Structural Information from Molecular Graphs. The TOPS-MODE Approach. Adv. Quantum Chem. In press.
26. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhet, J. N.; Weissing, H.; Shindyalor, I. N.; Bourne, P. E. The Protein Data Bank. Nucleic Acids Res. 2000, 28, 235-242.
27. Soboler, V.; Sorokine, A.; Prilusky, J.; Abola, E. E.; Edelman, M. Automated Analysis of Interatomic Contacts in Protein. Bioinformatics 1999, 15, 327-332.
28. Estrada, E. Spectral Moments of the Edge Adjacency Matrix in Molecular Graph. 1. Definition and Applications to the Prediction of Physical Properties of Alkanes. J. Chem. Inf. Comput. Sci. 1996, 36, 844-849.
29. Estrada, E. Spectral Moments of the Edge Adjacency Matrix in Molecular Graph. 2. Molecules Containing Heteroatoms and QSAR Applications. J. Chem. Inf. Comput. Sci. 1997, 37, 320-328.
30. Estrada, E. Spectral Moments of the Edge Adjacency Matrix in Molecular Graph. 3. Molecules Containing Cycles. J. Chem. Inf. Comput. Sci. 1998, 38, 23-27.
31. Estrada, E.; Peña, A.; García-Domenech, R. Designing Sedative/Hypnotic Compounds from a Novel Substructural Graph - Theoretical Approach. J. Comput.-Aided Mol. Des. 1998, 12, 583-595.
32. Estrada, E.; Uriarte, E.; Montero. A.; Teijeira, M.; Santana, L.; De Clercq, E. A Novel Approach to the Rational Selection and Design of Anticancer Compounds. J. Med. Chem. 2000, 43, 1975-1985.
33. Estrada, E. Edge Adjacency Relationships and o Novel Topological Index Related to Molecular Volume., J. Chem. Inf. Comput. Sci. 1995, 35, 31-33.
34. Wang, R.; Gao, Y.; Lai, L. Calculating Partition Coefficient by AtomAdditive Method. Perspect. Drug Discovery Des. 2000, 19, 47-66.
35. Ertl, P.; Rhode, P.; Selzer, P. Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Applications to the Prediction of Drug Transport Properties. J. Med. Chem. 2000, 43, 3714-3717.
36. Ghose, A. K.; Crippen, G. M. Atomic Physicochemical Parameters for Three-Dimensional-Structure-Directed Quantitative Structure-Activity Relationships. 2. Modeling Dispersive and Hydrophobic Interactions. J. Chem. Inf. Comput. Sci. 1987, 27, 21-35.
37. Bondi, A. van der Waals Volumes and Radii. J. Phys. Chem. 1964. 68, 441-451.
38. Gasteiger, J.; Marsilli, M. A New Model for Calculating Atomic Charges in Molecules. Tetrahedron Lett. 1978, 34, 3181-3184.
39. Baskin, I. I.; Skvortsova, M. I.; Stankevich, I. V.; Zefirov, N. S. On the Basis of Invariants of Labeled Molecular Graphs. J. Chem. Inf. Comput. Sci. 1995, 35, 527-531.
40. Zefirov, N. S.; Palyulin, V. A. Fragmental Approach in QSPR. J. Chem. Inf. Comput. Sci. 2002, 42, 1112-1122.
41. Randić, M. Resolution of Ambiguities in Structure-Property Studies by Use of Orthogonal Descriptors. J. Chem. Inf. Comput. Sci. 1991, 31, 311-320.
42. Randić, M. Orthogonal Molecular Descriptors. New J. Chem. 1991, 15, 517-525.
43. Randić, M. Correlation of Enthalpy of Octanes with Orthogonal Connectivity Indices. THEOCHEM 1991, 233, 45-49.
44. Lučić, B.; Nicolić, S.; Trinajstić, N.; Jurić, D. The Structure-Property Models Can Be Improved Using the Orthogonalized Descriptors. J. Chem. Inf. Comput. Sci. 1995, 35, 532-538.
45. Klein, D. J.; Randić, M.; Babić, D.; Lučić, B.; Nicolić, S.; Trinajstić, N. Hierarchical Orthogonalization of Descriptors. Int. J. Quantum Chem. 1997, 63, 215-222.
46. Estrada, E.; Molina, E. Novel Local (Fragment-Based) Topological Molecular Descriptors for QSPR/QSAR and Molecular Design. J. Mol. Graphics Modell. 2001, 20, 54-64.
47. Estrada, E.; Molina, E. Automatic Extraction of Structural Alerts for Predicting Chromosome Aberrations of Organic Compounds. J. Mol. Graphies Modell. 2006, 25, 275-288.
48. Estrada, E. Molina, E.; Perdomo-López, I. Can 3D Structural Parameters Be Predicted from 2D (topological) Molecular Descriptors. J. Chem. Inf. Comput. Sci. 2001, 41, 1015-1021.
49. Zatón, A. M. L.; Villamor, J. P. Study of Heterocycle Rings Binding to Human Serum Albumin. Chem.-Biol. Interact. 2000, 124, 1-11.
50. Hage, D. S.; Sengupta, A. Characterization of the Binding of Digitoxin and Acetyldigitoxin to Human Serum Albumin by High-Performance Affinity Chromatography. J. Chromatogr., B 1999, 724, 91-100.
51. Bertucci, C.; Domenici, E. Reversible and Covalent Binding of Drugs to Human Serum Albumin: Methodological Approaches and Physiological Relevance. Curr. Med. Chem. 2002, 9, 1463-1481.
52. Andrews, P. R.; Craik, D. J.; Martin, J. L. Functional Group Contributions to Drug-Receptor Interactions. J. Med. Chem. 1984, 27, 1648-1657.
53. Williams, D. H.; Cox, J. P. L.; Doig, A. J.; Gardner, M.; Gerhard, U.: Kaye, P. T.; Lal, A. R.; Nicholls, I. A.; Salter, C. J. Mitchell, R. C. Toward the Semiquantitative Estimation of Binding Constants. Guides for Peptide-Peptide Binding in Aqueous Solution. J. Am. Chem. Soc. 1991, 113, 7020-7030.
54. Williams, D. H.; Stephens, E.; O'Brien D. P.; Zhou, M. Understanding Noncovalent Interactions: Ligand Binding Energy and Catalytic Efficiency from Ligand-Induced Reductions in Motion within Receptors and Enzymes. Angew. Chem., Int. Ed. 2004, 43, 6596-6616.
55. Böhm, H. J. The Development of a Simple Empirical Scoring Function to Estimate the Binding Constant for a Protein-Ligand Complex of Known Three-Dimensional Structure. J. Comput.-Aided Mol. Des. 1994, 8, 243-256.
56. Urien, S.; Nguyen, P.; Berilos, S.; Brée, F.; Vacherot, F.; Tillement, J. P. Characterization of Discrete Classes of Binding Sites of Human Serum Albumin by Application of Thermodynamic Principles. Biochem. J. 1994, 302, 69-72.
57. Aki, H.; Yamamoto, M. Thermodynamic Characterization of Drug Binding to Human Serum Albumin by Isothermal Titration Microcalorimetry. J. Phamacol. Sci. 1994, 83, 1712-1716.
58. Strogatz, S. H. Exploring Complex Networks. Nature (London) 2001, 2, 268-276.
59. Albert, R.; Barabási, A. L. Statistical Mechanics of Complex Networks. Rev. Mod. Phys. 2002, 74, 47-97.
60. Newman, M. E. J. The Structure and Function of Complex Networks. SIAM Rev. 2003, 45, 167-256.
61. Watts, D. J.; Strogatz, S. H. Collective Dynamics of "Small- World" Networks. Nature (London) 1998, 393, 440-448.
62. Barabási, A. L.; Albert, R. Emergence of Scaling in Random Networks. Science 1999, 286, 509-512.
63. Bemis, G. W.; Murcko, M. A. The Properties of Known Drugs. 1. Molecular Frameworks. J. Med. Chem. 1996, 39, 2887-2893.
64. Bemis, G. W.; Murcko, M. A. The Properties of Known Drugs. 2. Side Chains. J. Med. Chem. 1999, 42, 5095-5099.